Philippe Lagrange
Philippe Lagrange has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Ana Lebreiro
Centro Hospitalar Universitario de Sao Joao, Faculdade de Medicina da Universidade do Porto, Portugal
2 shared publications - Carolina Saleiro
Pacing & Electrophysiology Unit, Cardiology Department Coimbra's Hospital and University Center Coimbra Portugal
2 shared publications - Lino Gonçalves
Cardiology Department-ULSCoimbra, iCBR-Faculty of Medicine, University of Coimbra , Coimbra, Portugal
2 shared publications - Luis Adão
Cardiology Department, University Hospital Center of São João , Porto , Portugal
2 shared publications Luís Elvas
Pacing & Electrophysiology Unit, Cardiology Department, Coimbra’s Hospital and University Center , Morada: Praceta Prof Mota Pinto, 3000-075 Coimbra , Portugal
2 shared publications- Luís Puga
Cardiology Department, Centro Hospitalar de Entre Douro e Vouga , Santa Maria da Feira , Portugal
2 shared publications
Latest Publications
- Open Access
- 31 May 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (6)
Real-world assessment of multipolar and point-by-point mapping for premature ventricular contraction ablation
Aims: We aimed to assess the acute and midterm efficacy of premature ventricular contraction (PVC) ablation guided by multielectrode and point-by-point (PbP) mapping. Methods and results: This is a retrospective, international multicentre study of consecutive patients referred for PVC ablation in 10 hospital centres from January 2017 to December 2021. Based on the mapping approach, two cohorts were identified: the ‘Multipolar group’, where a dedicated high-density mapping catheter was employed, and the ‘PbP group’, where mapping was performed with the ablation catheter. Procedural endpoints, safety, and acute (procedural) and midterm efficacies were assessed. Of the 698 patients included in this study, 592 received activation mapping [46% males, median age of 55 (41–65) years]—248 patients in the Multipolar group and 344 patients in the PbP group. A higher number of activation points [432 (217–843) vs. 95 (42–185), P < 0.001], reduced mapping time (40 ± 38 vs. 61 ± 50 min, P < 0.001), and shorter procedure time (124 ± 60 vs. 143 ± 63 min, P < 0.001) were reported in the Multipolar group. Both groups had high acute success rates (84.7% with Multipolar mapping vs. 81.3% with PbP mapping, P = 0.63), as well as midterm efficacy (83.4% vs. 77.4%, P = 0.08), with no significant differences in the risk of adverse events (6.0% vs. 3.5%, P = 0.24). However, for left-sided PVC ablation specifically, there was a higher midterm efficacy in the Multipolar group (80.7% vs. 69.5%, P = 0.04), with multipolar mapping being an independent predictor of success [adjusted OR = 2.231 (95% CI, 1.476–5.108), P = 0.02]. Conclusion: The acute and midterm efficacies of PVC ablation are high with both multipolar and PbP mapping, although the former allows for quicker procedures and may potentially improve the outcomes of left-sided PVC ablation.
- 31 May 2024
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 26 (6)
Open AccessReal-world assessment of multipolar and point-by-point mapping for premature ventricular contraction ablation
Aims: We aimed to assess the acute and midterm efficacy of premature ventricular contraction (PVC) ablation guided by multielectrode and point-by-point (PbP) mapping. Methods and results: This is a retrospective, international multicentre study of consecutive patients referred for PVC ablation in 10 hospital centres from January 2017 to December 2021. Based on the mapping approach, two cohorts were identified: the ‘Multipolar group’, where a dedicated high-density mapping catheter was employed, and the ‘PbP group’, where mapping was performed with the ablation catheter. Procedural endpoints, safety, and acute (procedural) and midterm efficacies were assessed. Of the 698 patients included in this study, 592 received activation mapping [46% males, median age of 55 (41–65) years]—248 patients in the Multipolar group and 344 patients in the PbP group. A higher number of activation points [432 (217–843) vs. 95 (42–185), P < 0.001], reduced mapping time (40 ± 38 vs. 61 ± 50 min, P < 0.001), and shorter procedure time (124 ± 60 vs. 143 ± 63 min, P < 0.001) were reported in the Multipolar group. Both groups had high acute success rates (84.7% with Multipolar mapping vs. 81.3% with PbP mapping, P = 0.63), as well as midterm efficacy (83.4% vs. 77.4%, P = 0.08), with no significant differences in the risk of adverse events (6.0% vs. 3.5%, P = 0.24). However, for left-sided PVC ablation specifically, there was a higher midterm efficacy in the Multipolar group (80.7% vs. 69.5%, P = 0.04), with multipolar mapping being an independent predictor of success [adjusted OR = 2.231 (95% CI, 1.476–5.108), P = 0.02]. Conclusion: The acute and midterm efficacies of PVC ablation are high with both multipolar and PbP mapping, although the former allows for quicker procedures and may potentially improve the outcomes of left-sided PVC ablation.
- Open Access
- 2 June 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (6)
Ostial vs. wide area circumferential ablation guided by the Ablation Index in paroxysmal atrial fibrillation
Pulmonary vein isolation (PVI) guided by the Ablation Index (AI) has shown high acute and mid-term efficacy in the treatment of paroxysmal atrial fibrillation (AF). Previous data before the AI-era had suggested that wide-area circumferential ablation (WACA) was preferable to ostial ablation. However, with the use of AI, we hypothesize that ostial circumferential ablation is non-inferior to WACA and can improve outcomes in paroxysmal AF. Prospective, multicentre, non-randomized, non-inferiority study of consecutive patients were referred for paroxysmal AF ablation from January 2020 to September 2021. All procedures were performed using the AI software, and patients were separated into two different groups: WACA vs. ostial circumferential ablation. Acute reconnection, procedural data, and 1-year arrhythmia recurrence were assessed. During the enrolment period, 162 patients (64% males, mean age of 60 ± 11 years) fulfilled the study inclusion criteria—81 patients [304 pulmonary vein (PV)] in the WACA group and 81 patients (301 PV) in the ostial group. Acute PV reconnection was identified in 7.9% [95% confidence interval (CI), 4.9–11.1%] of PVs in the WACA group compared with 3.3% (95% CI, 1.8–6.1%) of PVs in the ostial group [P < 0.001 for non-inferiority; adjusted odds ratio 0.51 (95% CI, 0.23–0.83), P = 0.05]. Patients in the WACA group had longer ablation (35 vs. 29 min, P = 0.001) and procedure (121 vs. 102 min, P < 0.001) times. No significant difference in arrhythmia recurrence was seen at 1-year of follow-up [11.1% in WACA vs. 9.9% in ostial, hazard ratio 1.13 (95% CI, 0.44–1.94), P = 0.80 for superiority]. In paroxysmal AF patients treated with tailored AI-guided PVI, ostial circumferential ablation is not inferior to WACA with regard to acute PV reconnection, while allowing quicker procedures with less ablation time. Distribution of acute pulmonary vein reconnection in both groups [wide-area circumferential ablation (WACA) vs. ostial] (central panel), with an illustration of the typical location for ablation lines in each corresponding group, in a posterior view (left panel). Ostial ablation was not inferior to WACA with regard to acute pulmonary vein reconnections (P < 0.001 for non-inferiority; P = 0.05 adjusted for superiority) and arrhythmia recurrence at 1-year of follow-up (P < 0.001 for non-inferiority; P = 0.80 for superiority), while requiring less ablation (P = 0.001) and allowing for quicker procedures (P < 0.001) (right panel).
- 2 June 2023
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (6)
Open AccessOstial vs. wide area circumferential ablation guided by the Ablation Index in paroxysmal atrial fibrillation
Pulmonary vein isolation (PVI) guided by the Ablation Index (AI) has shown high acute and mid-term efficacy in the treatment of paroxysmal atrial fibrillation (AF). Previous data before the AI-era had suggested that wide-area circumferential ablation (WACA) was preferable to ostial ablation. However, with the use of AI, we hypothesize that ostial circumferential ablation is non-inferior to WACA and can improve outcomes in paroxysmal AF. Prospective, multicentre, non-randomized, non-inferiority study of consecutive patients were referred for paroxysmal AF ablation from January 2020 to September 2021. All procedures were performed using the AI software, and patients were separated into two different groups: WACA vs. ostial circumferential ablation. Acute reconnection, procedural data, and 1-year arrhythmia recurrence were assessed. During the enrolment period, 162 patients (64% males, mean age of 60 ± 11 years) fulfilled the study inclusion criteria—81 patients [304 pulmonary vein (PV)] in the WACA group and 81 patients (301 PV) in the ostial group. Acute PV reconnection was identified in 7.9% [95% confidence interval (CI), 4.9–11.1%] of PVs in the WACA group compared with 3.3% (95% CI, 1.8–6.1%) of PVs in the ostial group [P < 0.001 for non-inferiority; adjusted odds ratio 0.51 (95% CI, 0.23–0.83), P = 0.05]. Patients in the WACA group had longer ablation (35 vs. 29 min, P = 0.001) and procedure (121 vs. 102 min, P < 0.001) times. No significant difference in arrhythmia recurrence was seen at 1-year of follow-up [11.1% in WACA vs. 9.9% in ostial, hazard ratio 1.13 (95% CI, 0.44–1.94), P = 0.80 for superiority]. In paroxysmal AF patients treated with tailored AI-guided PVI, ostial circumferential ablation is not inferior to WACA with regard to acute PV reconnection, while allowing quicker procedures with less ablation time. Distribution of acute pulmonary vein reconnection in both groups [wide-area circumferential ablation (WACA) vs. ostial] (central panel), with an illustration of the typical location for ablation lines in each corresponding group, in a posterior view (left panel). Ostial ablation was not inferior to WACA with regard to acute pulmonary vein reconnections (P < 0.001 for non-inferiority; P = 0.05 adjusted for superiority) and arrhythmia recurrence at 1-year of follow-up (P < 0.001 for non-inferiority; P = 0.80 for superiority), while requiring less ablation (P = 0.001) and allowing for quicker procedures (P < 0.001) (right panel).
- 20 May 2015
- Published by CAIRN.INFO
- p. 189-209
Les libertés politiques
- 1 January 2012
- Published by PERSEE Program in Annuaire français de droit international
- Vol. 58 (1) , 349-391
Travaux de la Commission du droit international et de la sixième commission
Norodom Anne-Thida, Lagrange Philippe. Travaux de la Commission du droit international et de la sixième commission. In: Annuaire français de droit international, volume 58, 2012. pp. 349-391
- 1 January 2012
- Published by PERSEE Program in Annuaire français de droit international
- Vol. 58 (1) , 349-391
Travaux de la Commission du droit international et de la sixième commission
Norodom Anne-Thida, Lagrange Philippe. Travaux de la Commission du droit international et de la sixième commission. In: Annuaire français de droit international, volume 58, 2012. pp. 349-391
- Open Access
- 1 October 2005
- Published by Elsevier in La Presse Médicale
- Vol. 34 (17) , 1245-1253
Vaccination antivirale et immunité muqueuse respiratoire
- 1 October 2005
- Published by Elsevier in La Presse Médicale
- Vol. 34 (17) , 1245-1253
Open AccessVaccination antivirale et immunité muqueuse respiratoire
- 1 August 1994
- Published by Elsevier in The American Journal of Medicine
- Vol. 97 (2) , 196-197
Combined therapy with ganciclovir and foscarnet for cytomegalovirus polyradiculomyelitis in patients with AIDS
- 1 August 1994
- Published by Elsevier in The American Journal of Medicine
- Vol. 97 (2) , 196-197
Combined therapy with ganciclovir and foscarnet for cytomegalovirus polyradiculomyelitis in patients with AIDS